A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma.
Gortzak E, Azzarelli A, Buesa J, Bramwell VH, van Coevorden F, van Geel AN, Ezzat A, Santoro A, Oosterhuis JW, van Glabbeke M, Kirkpatrick A, Verweij J; E.O.R.T.C. Soft Tissue Bone Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group/Canadian Sarcoma Group.
Gortzak E, et al.
Eur J Cancer. 2001 Jun;37(9):1096-103. doi: 10.1016/s0959-8049(01)00083-1.
Eur J Cancer. 2001.
PMID: 11378339
Clinical Trial.